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Abstract
The objective of the study is to determine the level of calcium in patients with hypertension of the II degree and generalized
periodontitis of the II degree.
There were examined 30 patients with hypertension of the II degree with generalized periodontitis of the II degree. Patients’
age ranged from 35 to 54 years. These patients were in the main group. Treatment of patients included taking the medicine
”Ca-D3 NIKOMED”.
The control group included 10 patients without general somathic pathology and with healthy periodontitis of the same age.
The results obtained were subject to variational and statistical processing.
The analyses were carried out before and 3 months after the treatment. The level of general Ca in patients with generalized
periodontitis of the II degree and hypertension of the II degree before the treatment was 1.66±0.03 mmol/l (p<0.001) (norm
2.15-2.5 mmol/l). In the patients of control group this figure was 2.33±0.04 mmol/l (p<0.001).
After 3 months the level of general Ca in patients with generalized periodontitis of the II degree and hypertension of the II
degree was 1.87±0.03 mmol/l (p<0.001).
The level of ionized Ca in patients with generalized periodontitis of the II degree and hypertension of the II degree before the
treatment was 0.36± 0.01 mmol/l (p<0.001); after the treatment the level of ionized Ca was 0.41±0.01 mmol/l (p<0.001).
The level of ionized Ca in control group patients was 1.03±0.02 mmol/l (p<0.001).
We can conclude: according to the analysis of levels of general and ionized calcium in serum of patients with generalized
periodontitis of the II degree and hypertension of the II degree we can conclude that these indexes are lower than normal;
patients with generalized periodontitis of the II degree and hypertension of the II degree have increased levels of general
calcium and ionized calcium in serum after taking the drug ”Ca-D3 NIKOMED”during 3 months.
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Problem statement and analysis of the
recent research
Calcium - is a unique element, which plays an important role
in a human life [6, 11]. Calcium and its compounds play an
important role in contracting skeletal and cardiac muscles,
intracellular secretion, mediator excitation in synapses, the
generation of potentials in some activate structures, main-
taining the necessary balance between activation and inhibi-
tion in the cerebral cortex, affecting peroxide lipid oxidation,
transportation of ions through a cell membrane, activity of
various groups of enzymes, humoral and cellular immunity,
hemodynamics and microcirculation, aggregate state of blood,
glycogenolysis and glucone genesis, hormonal secretion, io-
dine exchange, growth and bone formation, mineralization of
bone tissue, functioning of the hypothalamic-pituitary system,
etc. [2, 3, 5, 9, 12, 14].
About 99% of calcium is found in bone and cartilage tis-
sues in the form of hydroxyapatite crystals (the main depot
of Ca in the organism), the rest - in soft tissues and extracel-
lular fluid [1, 15, 16, 17]. Concentration of calcium ions in
blood serum is one of the most important constants of home-
ostasis. 50% of calcium is represented in an ionized form in
blood serum and extracellular fluid (biologically active frac-
tion); 40% - is in a protein-bound state, mainly with albumins
(biologically inert calcium) [10, 13, 14, 15].
The exchange of phosphorus is closely connected with
the exchange of calcium [3, 7, 11]. Bone tissue contains 80%
of the total amount of phosphorus (in the form of crystals of
hydroxyapatite). Adequate concentration of phosphorus in
blood is the necessary condition for normal mineralization [2,
6, 9, 11, 12, 13].
It is known that calcium and phosphorus take part in the
metabolism of bone tissue, which, in turn, plays an important
role in the maintenance of constant concentration of these
elements in blood. Bones contain 89% of the total calcium
of the body, 87% of phosphorus, 58% of magnesium, a large
amount of potassium and sodium, and other elements [16, 18].
Bone tissue - is a dynamic, metabolically active system,
which consists of organic and inorganic components [4, 8].
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The organic part of the bone (osteoid) is represented by a
collagen matrix and non-collagen proteins. The inorganic
component is represented by hydroxyapatite, which initially
deposits on the organic matrix as a salt of calcium hydrox-
yphosphate and then becomes an apatite crystal. About 60%
of the mineral component of the bone may be amorphous
calcium phosphate, which is a mobile reserve of calcium and
phosphorus, acts as an exchange part and ensures the needs of
the whole organism.
The cellular composition of the bone is represented by
osteoblasts, osteocytes and osteoclasts. The main function
of osteoclasts is the resorbtion of bone matrix [8, 18]. It has
been proved, that the activation of osteoclasts is influenced
by FNP-a, IL-1, IL-6. Basic functions of osteoblasts are: syn-
thesis of collagen and the formation of its fibers, synthesis of
non-collagen proteins, synthesis of enzymes (alkaline phos-
phatase, collagenase, plasminogen activator), participation in
the transport of calcium and phosphate in the bone matrix
and the development of hydroxyapatite crystals. In the further
development osteoblasts are transformed into osteocytes - the
most numerous bone marrow cells that are included into the
intercellular matrix and support the structure of bone tissue.
Osteocytes perform the following functions: stimulate the
synthesis of collagen and glycosaminoglycans, participate in
metabolism (protein, water, mineral) of bone tissue and the
formation of a new bone.
The structural integrity of the skeleton is supported by a
continuous process of bone remodeling. Bone remodeling
begins in the womb and lasts during the whole life [16].
Remodeling of bone tissue plays a key role in bone home-
ostasis and metabolic processes in the body. It is a permanent
physiological process, the main function of which is the reno-
vation of bone structures, adaptation to mechanical stresses,
and the maintenance of mineral metabolism of calcium and
phosphorus [7]. The process of remodeling is controlled by
hormones, a number of local biologically active substances
(polypeptide growth factors and cytokines).
A sufficient amount of calcium is required for bone tissue
mineralization (remineralization) in the areas of bone resorp-
tion. Bone tissue is a depot of calcium and, at the same time,
calcium determines the strength of the bones, performing a
structural function. After the age of 40 years the process of
bone resorbtion prevails over bone formation, which leads to
a gradual decrease in the mass and strength of the bone.
The objective of the study.The objective of the study is to
determine the level of calcium in patients with hypertension
of the II degree and generalized periodontitis of the II degree.
1. Materials and methods of the research
There were examined 30 patients with hypertension of the
II degree and with generalized periodontitis of the II degree.
Patients’ age ranged from 35 to 54 years. These patients
were included into the main group. The control group in-
cluded 10 patients without general somathic pathology and
and the healthy periodontium of the same age. The diagnosis
of periodontal diseases was made accordin to the anamnesis,
clinical dental examination and generally accepted additional
methods of examination. The classification according to M.F.
Danilevsky (1994) was used during diagnostics of the diseases
of periodontium.
Treatment of patients included the medicine ”Ca-D3 NIKOMED”:
patients took 2 tablets a day (in the morning and evening).
Blood collection was performed before the beginning of treat-
ment and after 3 months of treatment.
The principle of the method for calcium content determin-
ing in the blood serum is that Ca ions in the alkaline medium
react with o-cresol phthalein complexon and form a coloured
complex. The intensity of the staining of the purple colour
complex is proportional to the concentration of calcium in the
experimental sample.
The obtained results were subjected to variation-statistical
analysis using statistical package ”Stat Soft 6.0”; classical
methods of variation statistics using mean ranges and assess-
ment of their authenticity.
2. Results of the research and their
discussion
The analyses were performed before and 3 months after the
treatment. The level of general Ca in patients with generalized
periodontitis of the II degree and hypertension of the II degree
before the treatment was 1.66±0.03 mmol/l (p<0.001) (norm
2.15-2.5 mmol/l). In the control group patients this figure was
2.33±0.04 mmol/l (p<0.001).
After 3 months of the treatment the level of general Ca
in patients with generalized periodontitis of the II degree
and hypertension of the II degree was 1.87±0.03 mmol/l
(p<0.001).
The level of ionized Ca in patients with generalized pe-
riodontitis of the II degree and hypertension of the II degree
before the treatment was 0.36±0.01 mmol/l (p<0.001); after
the treatment the level of ionized Ca was 0.41±0.01 mmol/l
(p<0.001). The level of ionized Ca in control group patients
was 1.03±0.02 mmol/l (p<0.001).
Taking Ca has a positive effect on the treatment, although
after the administration of the medicine within 3 months, the
optimal level of calcium in the blood serum has not been
achieved. Increased levels of general and ionized calcium
have been noted.
3. Conclusions
1. According to the analysis of levels of general and ion-
ized calcium in blood serum in patients with generalized
periodontitis of the II degree and hypertension of the
II degree we can conclude that these indeces are lower
than the normal ones.
2. After taking the medicine ”Ca-D3 NIKOMED” during
3 months there are increased indeces of general and
ionized Ca in blood serum in patients with generalized
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Figure 1. Indicators of calcium metabolism in patients with
generalized periodontitis and hypertension
Note. Probability of differences between control and main groups,
p<0.001.
periodontitis of the II degree and hypertension of the II
degree.
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